http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5793998-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5d04736b0b882a4f5a1e0e0e4cd8cbb
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J75-00
filingDate 1980-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_455bb77e45f359c7babf61f3be8a90a4
publicationDate 1982-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S5793998-A
titleOfInvention Preparation of delta11 unsaturated steroid
abstract PURPOSE: To prepare the titled compound useful as an intermediate of a gallstone-dissolving agent, at a low cost, by the desulfonation reaction of a steroid compound containing an alkylsulfonyl group in the presence of a phase-transfer catalyst such as a specific metal salt, a quaternary ammonium salt, etc. n CONSTITUTION: The objective steroid compound can be prepared by the desulfonation reaction of a steroid compound having an alkylsulfonyl group at 12- position in the presence of a phase-transfer catalyst consisting of (A) one or more compounds selected from halides and (haogeno) lower carboxylic acid salts of alkali or alkaline earth metals, (B) one or more compounds selected from carbonates, bicarbonates, monohydrogenphosphates, sulfites, hydroxides and amide salts of alkali or alkaline earth metals, and (C) one or more compounds selected from quaternary ammonium salts, quaternary phosphonium salts and crown ethers, pref. in a solvent at 110W130°C for 4W18hr. The amounts of the catalyst components (A), (B) and (C) are pref. 2W0.5pts., 0.5W0.05pt., and 0.1W0.01pt. per 1pt. of the starting steroid compound, respectively. n COPYRIGHT: (C)1982,JPO&Japio
priorityDate 1980-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407832258
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3681305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588021
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID769
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550720
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1099

Total number of triples: 18.